- Home
- Publications
- Publication Search
- Publication Details
Title
P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 4, Pages 1391
Publisher
MDPI AG
Online
2020-02-20
DOI
10.3390/ijms21041391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake
- (2020) Kok Weng Ow et al. PLATELETS
- Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
- (2019) Thiago A. Patente et al. Frontiers in Immunology
- Acute respiratory distress syndrome
- (2019) Michael A. Matthay et al. Nature Reviews Disease Primers
- Evaluation of adverse events involving bleeding associated with oral P2Y12 inhibitors use in the Food and Drug Administration adverse event reporting system
- (2019) Ahmed I. Fahmy et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacology of P2Y Receptors
- (2019) Ivar von Kügelgen BRAIN RESEARCH BULLETIN
- Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria
- (2019) Patrizio Lancellotti et al. JAMA Cardiology
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- Platelets Are Critical Key Players in Sepsis
- (2019) Fanny Vardon-Bounes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome
- (2019) Marc Laine et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
- (2019) Ana Luisa Palacios-Acedo et al. Frontiers in Immunology
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- Platelets in Sepsis: An Update on Experimental Models and Clinical Data
- (2019) Alice Assinger et al. Frontiers in Immunology
- Targeting Delivery of Platelets Inhibitor to Prevent Tumor Metastasis
- (2019) Marzieh Geranpayehvaghei et al. BIOCONJUGATE CHEMISTRY
- Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
- (2019) Nina Wolska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microglia monitor and protect neuronal function through specialized somatic purinergic junctions
- (2019) Csaba Cserép et al. SCIENCE
- ADP exerts P2Y12 -dependent and P2Y12 -independent effects on primary human T cell responses to stimulation
- (2019) Harika Vemulapalli et al. Journal of Cell Communication and Signaling
- Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome
- (2018) Elizabeth A. Middleton et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice
- (2018) Byambasuren Ganbaatar et al. ATHEROSCLEROSIS
- P2Y12 receptor modulation of ADP-evoked intracellular Ca2+ signalling in THP-1 human monocytic cells
- (2018) J J Micklewright et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Platelet Lifeline to Cancer: Challenges and Opportunities
- (2018) Monika Haemmerle et al. CANCER CELL
- Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones
- (2018) Omar Elaskalani et al. Cell Communication and Signaling
- Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea
- (2018) Luis Ortega-Paz et al. CIRCULATION
- Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease
- (2018) Sammy Elmariah et al. Circulation-Cardiovascular Interventions
- Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer
- (2018) Alison J. Gareau et al. CLINICAL & EXPERIMENTAL METASTASIS
- A trial of type 12 purinergic (P2Y 12 ) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease
- (2018) Tanya M. Laidlaw et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunosuppressive Effect of Ticagrelor on Dendritic Cell Function: A New Therapeutic Target of Antiplatelet Agents in Cardiovascular Disease
- (2018) Lizhen Liao et al. Journal of Biomedical Nanotechnology
- Current and future antiplatelet therapies: emphasis on preserving haemostasis
- (2018) James D. McFadyen et al. Nature Reviews Cardiology
- Platelet activation and antiplatelet therapy in sepsis: A narrative review
- (2018) Yuhui Wang et al. THROMBOSIS RESEARCH
- Recent advances in understanding the roles of blood platelets in the pathogenesis of allergic inflammation and bronchial asthma
- (2018) Tomohiro Takeda et al. ALLERGOLOGY INTERNATIONAL
- P2Y12 Receptors in Tumorigenesis and Metastasis
- (2018) Patrizia Ballerini et al. Frontiers in Pharmacology
- Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)
- (2018) Anne Godier et al. Anaesthesia Critical Care & Pain Medicine
- The role of P2Y12 receptor in ischemic stroke of atherosclerotic origin
- (2018) Ying Gao et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor
- (2018) Cédric Garcia et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer
- (2018) Antonio Rodríguez-Miguel et al. Clinical Gastroenterology and Hepatology
- Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery
- (2018) Younis Baqi et al. DRUG DISCOVERY TODAY
- Clopidogrel reduces lipopolysaccharide‐induced inflammation and neutrophil‐platelet aggregates in an experimental endotoxemic model
- (2018) Xiao‐Li Wang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Ticagrelor suppresses oxidized low‑density lipoprotein‑induced endothelial cell apoptosis and alleviates atherosclerosis in ApoE‑/‑ mice via downregulation of PCSK9
- (2018) Xiaodong Xia et al. Molecular Medicine Reports
- Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y12 antagonists
- (2018) Magdalena Boncler et al. VASCULAR PHARMACOLOGY
- Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation
- (2018) Jan Rossaint et al. Frontiers in Immunology
- Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor
- (2018) Sergio Raposeiras-Roubín et al. THROMBOSIS RESEARCH
- Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis
- (2017) T. Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- P2Y12Receptor Modulates Sepsis-Induced InflammationSignificance
- (2016) Elisabetta Liverani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
- (2016) R. Aungraheeta et al. BLOOD
- Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression
- (2016) Martin F. Reiner et al. CARDIOVASCULAR RESEARCH
- Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis
- (2016) Rafail Angelos Kotronias et al. DRUG SAFETY
- Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
- (2016) Janette Bester et al. Scientific Reports
- Intercellular Interactions as Regulators of NETosis
- (2016) Nayef M. Kazzaz et al. Frontiers in Immunology
- Platelets: New Bricks in the Building of Neutrophil Extracellular Traps
- (2016) Agostina Carestia et al. Frontiers in Immunology
- Sepsis and septic shock
- (2016) Richard S. Hotchkiss et al. Nature Reviews Disease Primers
- Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion
- (2015) Hiroshi Satonaka et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Platelet P2Y12Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human ModelSignificance
- (2015) Mark R. Thomas et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Purinergic Receptors in Thrombosis and Inflammation
- (2015) Béatrice Hechler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- P-selectin promotes neutrophil extracellular trap formation in mice
- (2015) J. Etulain et al. BLOOD
- Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo
- (2015) Christian Heim et al. HEART AND VESSELS
- Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study
- (2015) Min-Juei Tsai et al. INTENSIVE CARE MEDICINE
- Ticagrelor shift from PLATO to PEGASUS: Vanished mortality benefit, excess cancer deaths, massive discontinuations, and overshooting target events
- (2015) Victor L. Serebruany INTERNATIONAL JOURNAL OF CARDIOLOGY
- Role of platelets in allergic airway inflammation
- (2015) Marco Idzko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma
- (2015) Dong-Hyeon Suh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- P2Y12receptors: structure and function
- (2015) M. Cattaneo JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients
- (2015) Blánaid M. Hicks et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effect of P2Y12 inhibitors on inflammation and immunity
- (2015) Robert Storey et al. THROMBOSIS AND HAEMOSTASIS
- The role of platelets in inflammation
- (2015) Robert Storey et al. THROMBOSIS AND HAEMOSTASIS
- Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response
- (2015) Valdirene S. Muniz et al. PLoS One
- Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
- (2014) Mark D. Turner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Vessel wall, not platelet, P2Y12 potentiates early atherogenesis
- (2014) L. E. West et al. CARDIOVASCULAR RESEARCH
- The Role of P2Y12 Receptor and Activated Platelets During Inflammation
- (2014) Elisabetta Liverani et al. CURRENT DRUG TARGETS
- The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer
- (2014) Simon Gebremeskel et al. INTERNATIONAL JOURNAL OF CANCER
- Adenosine-Mediated Effects of Ticagrelor
- (2014) Marco Cattaneo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study
- (2014) F. Lussana et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12-receptor
- (2014) K. Hoffmann et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Structure of the human P2Y12 receptor in complex with an antithrombotic drug
- (2014) Kaihua Zhang et al. NATURE
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
- (2014) Paul P. Dobesh et al. PHARMACOTHERAPY
- Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
- (2013) Philippe Gabriel Steg et al. LANCET
- P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer
- (2013) Sasmit Sarangi et al. MEDICAL ONCOLOGY
- Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
- (2013) Robert F. Storey et al. PLATELETS
- Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis
- (2013) Milladur Rahman et al. PLATELETS
- Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis
- (2013) Yanhua Wang et al. PLoS One
- Roles of Purinergic Receptor P2Y, G Protein–Coupled 12 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2012) Ding Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Stable Coronary Artery Disease
- (2012) Steen E. Husted et al. CLINICAL PHARMACOKINETICS
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
- (2012) Dominick J. Angiolillo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
- (2012) Xinming Su et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- The platelet P2Y12 receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [3H]PSB-0413
- (2012) Philippe Ohlmann et al. Purinergic Signalling
- P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells
- (2012) Christian Gachet Purinergic Signalling
- Comparison of Differential Expression of P2Y12 Receptor in Culprit Coronary Plaques in Patients With Acute Myocardial Infarction Versus Stable Angina Pectoris
- (2011) Cheol Whan Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2011) R. C. Becker et al. EUROPEAN HEART JOURNAL
- The roles of thrombin and protease-activated receptors in inflammation
- (2011) Liang Ma et al. Seminars in Immunopathology
- Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate
- (2011) Marco Cattaneo THROMBOSIS AND HAEMOSTASIS
- Platelets in atherosclerosis
- (2011) Philipp von Hundelshausen et al. THROMBOSIS AND HAEMOSTASIS
- Regulation of Functionally Active P2Y12 ADP Receptors by Thrombin in Human Smooth Muscle Cells and the Presence of P2Y12 in Carotid Artery Lesions
- (2010) Bernhard H. Rauch et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite
- (2010) K. Hagihara et al. DRUG METABOLISM AND DISPOSITION
- Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
- (2010) R. Teng et al. DRUG METABOLISM AND DISPOSITION
- Role of the P2Y12 Receptor in the Modulation of Murine Dendritic Cell Function by ADP
- (2010) A. Ben Addi et al. JOURNAL OF IMMUNOLOGY
- Autocrine Purinergic Receptor Signaling Is Essential for Macrophage Chemotaxis
- (2010) M. Kronlage et al. Science Signaling
- Adenosine Diphosphate Receptor Antagonist Clopidogrel Sulfate Attenuates LPS-Induced Systemic Inflammation in a Rat Model
- (2010) Satoshi Hagiwara et al. SHOCK
- Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes
- (2009) Philipp Diehl et al. BASIC RESEARCH IN CARDIOLOGY
- CalDAG-GEFI is at the nexus of calcium-dependent platelet activation
- (2009) L. Stefanini et al. BLOOD
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use
- (2009) L. Wallentin EUROPEAN HEART JOURNAL
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- (2009) Nagy A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12receptor
- (2009) Sailaja Paruchuri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro
- (2009) Jennifer L Strande et al. Journal of Inflammation-London
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice
- (2009) Arnon Afek et al. MICROVASCULAR RESEARCH
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms
- (2009) Johannes Winning et al. PLATELETS
- Amicus or Adversary
- (2008) Fernando A. Bozza et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cangrelor Attenuates Coated-Platelet Formation
- (2008) Nicholas B. Norgard et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Clopidogrel Attenuates Coated-platelet Production in Patients Undergoing Elective Coronary Catheterization
- (2008) Nicholas B Norgard et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Formation of coated platelets is regulated by the dense granule secretion of adenosine 5′diphosphate acting via the P2Y12 receptor
- (2008) Y. N. KOTOVA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The active metabolite of prasugrel effectively blocks the platelet P2Y12receptor and inhibits procoagulant and pro-inflammatory platelet responses
- (2008) Heather M. Judge et al. PLATELETS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now